Long-term results after pulmonary resection of renal cell carcinoma metastases. 2002

Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
Department of Surgery and Thoracic Surgery, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Germany. spiltz@gch.med.uni-muenchen.de

BACKGROUND Until now no conclusive data exist regarding the factors influencing long-term survival after pulmonary resection of renal cell carcinoma metastases. The aim of the present study, therefore, was to discover definitive prognostic factors for survival using a large and homogeneous single center patient cohort. METHODS Between 1980 and 2000, 105 patients, after curative resection of lung metastases from renal cell carcinoma, were followed in this long-term study. These patients underwent a total of 150 surgical procedures. Survival analysis was done using the Kaplan-Meier method and the log-rank test. Multivariate analysis of prognostic factors was performed using the Cox multivariate proportional hazard model. RESULTS Median survival after curative resection reached 43 months (range, 1 to 218 months). Survival at 3, 5, and 10 years was 54%, 40%, and 33%, respectively. Univariate analysis revealed that a complete resection, a less than 4-cm diameter of the metastases and tumor-free lymph nodes at the time of primary operation, were highly significant dependent prognostic factors (p < 0.001). These factors were also shown to be independent prognostic factors as suggested by multivariate analysis (p < 0.05). CONCLUSIONS The size of the metastatic nodule, the completeness of pulmonary resection, and the lymph node status at the time of nephrectomy are the most important prognostic factors that influence survival after resection of pulmonary metastases. Recurrence of resectable pulmonary metastases does not impair survival, thus favoring repeated resection in patients with recurrent disease.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
December 2006, The Thoracic and cardiovascular surgeon,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
May 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
January 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
June 2021, Annals of surgical oncology,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
August 2009, Interactive cardiovascular and thoracic surgery,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
January 1999, Anticancer research,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
August 1992, The Annals of thoracic surgery,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
November 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
August 2011, American journal of surgery,
Stefan Piltz, and Georgios Meimarakis, and Matthias W Wichmann, and Rudolf Hatz, and Friedrich Wilhelm Schildberg, and Heinrich Fuerst
June 2021, Annals of surgical oncology,
Copied contents to your clipboard!